Your browser is no longer supported. Please, upgrade your browser.
BDX Becton, Dickinson and Company monthly Stock Chart
BDX [NYSE]
Becton, Dickinson and Company
IndexS&P 500 P/E83.35 EPS (ttm)2.73 Insider Own0.10% Shs Outstand289.87M Perf Week-2.57%
Market Cap66.23B Forward P/E17.08 EPS next Y13.32 Insider Trans-1.18% Shs Float289.64M Perf Month-6.87%
Income767.00M PEG8.77 EPS next Q3.03 Inst Own87.30% Short Float0.75% Perf Quarter-7.75%
Sales17.12B P/S3.87 EPS this Y24.40% Inst Trans-0.66% Short Ratio1.46 Perf Half Y-7.88%
Book/sh85.06 P/B2.67 EPS next Y6.26% ROA1.70% Target Price273.93 Perf Year-10.87%
Cash/sh9.97 P/C22.81 EPS next 5Y9.50% ROE4.20% 52W Range197.75 - 286.72 Perf YTD-16.36%
Dividend3.16 P/FCF39.85 EPS past 5Y-8.90% ROI4.30% 52W High-20.66% Beta0.79
Dividend %1.39% Quick Ratio1.00 Sales past 5Y15.40% Gross Margin47.10% 52W Low15.03% ATR5.30
Employees70093 Current Ratio1.50 Sales Q/Q-11.40% Oper. Margin9.40% RSI (14)38.40 Volatility1.76% 2.39%
OptionableYes Debt/Eq0.78 EPS Q/Q-21.40% Profit Margin5.40% Rel Volume1.08 Prev Close229.29
ShortableYes LT Debt/Eq0.71 EarningsNov 05 BMO Payout91.50% Avg Volume1.49M Price227.47
Recom2.10 SMA20-3.77% SMA50-3.00% SMA200-7.05% Volume1,615,521 Change-0.79%
Jul-09-20Upgrade Barclays Equal Weight → Overweight $300
Jun-01-20Resumed Goldman Buy $278
Mar-05-20Initiated Citigroup Neutral $260
Feb-07-20Downgrade Raymond James Strong Buy → Outperform $283
Feb-07-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20Downgrade Cowen Outperform → Market Perform
Feb-06-20Downgrade Cowen Outperform → Market Perform
Jan-08-20Downgrade Barclays Overweight → Equal Weight $275
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Dec-29-17Reiterated Deutsche Bank Buy $239 → $260
Nov-03-17Reiterated RBC Capital Mkts Sector Perform $210 → $230
Sep-22-17Initiated Wells Fargo Outperform $225
Nov-24-20 04:10PM  
Nov-23-20 06:58AM  
Nov-19-20 06:14PM  
04:18PM  
Nov-18-20 04:39PM  
Nov-17-20 07:15AM  
Nov-13-20 07:49AM  
Nov-12-20 06:58AM  
06:53AM  
Nov-11-20 07:09AM  
Nov-10-20 04:01PM  
Nov-09-20 04:20PM  
Nov-06-20 10:30PM  
Nov-05-20 07:00PM  
01:31PM  
10:41AM  
08:25AM  
07:30AM  
06:00AM  
Nov-04-20 07:58AM  
Nov-03-20 10:25AM  
Oct-29-20 12:35PM  
06:50AM  
Oct-26-20 11:12AM  
Oct-23-20 11:36AM  
09:25AM  
Oct-22-20 06:57AM  
Oct-21-20 09:29AM  
02:00AM  
Oct-20-20 07:00AM  
Oct-17-20 01:08AM  
Oct-16-20 11:04AM  
Oct-11-20 07:08AM  
Oct-09-20 01:56PM  
07:00AM  
Oct-07-20 06:55AM  
Oct-06-20 04:01PM  
09:12AM  
Oct-05-20 10:37AM  
06:52AM  
Oct-04-20 05:00PM  
Oct-02-20 04:10PM  
10:32AM  
Oct-01-20 02:22PM  
Sep-30-20 04:02PM  
01:02PM  
01:01PM  
05:02AM  
03:00AM  
Sep-29-20 03:09PM  
Sep-25-20 05:40PM  
Sep-23-20 06:59AM  
02:00AM  
Sep-21-20 07:06AM  
06:59AM  
Sep-17-20 07:00AM  
Sep-15-20 12:09PM  
11:07AM  
Sep-09-20 06:59AM  
Sep-05-20 11:31AM  
Sep-04-20 06:25PM  
Sep-03-20 06:44AM  
Sep-02-20 07:30AM  
Sep-01-20 12:27PM  
07:30AM  
Aug-31-20 05:06PM  
12:33PM  
Aug-29-20 09:09AM  
Aug-28-20 08:09AM  
Aug-27-20 06:09AM  
Aug-24-20 06:41PM  
Aug-20-20 04:01PM  
Aug-17-20 04:01PM  
Aug-13-20 08:57AM  
Aug-10-20 06:58AM  
06:03AM  
Aug-06-20 04:21PM  
04:14PM  
04:00PM  
02:34PM  
01:11PM  
12:00PM  
11:55AM  
10:58AM  
09:40AM  
09:22AM  
07:35AM  
07:00AM  
06:12AM  
06:00AM  
Aug-05-20 08:29AM  
Aug-04-20 07:32AM  
Aug-03-20 06:58AM  
Jul-30-20 10:26PM  
05:13PM  
02:00PM  
Jul-27-20 04:10PM  
Jul-23-20 01:37PM  
Jul-22-20 06:59AM  
05:30AM  
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral IV and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, IV fluids, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps and dedicated disposables, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. It has a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines for injection devices. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Goette RolandEVP and President, EMEANov 23Option Exercise76.643,485267,09010,085Nov 24 04:52 PM
Goette RolandEVP and President, EMEANov 23Sale230.10930213,9937,994Nov 24 04:52 PM
Kaltenbach PatrickEVP & Pres Life SciencesJul 09Sale260.001,272330,72010,340Jul 13 09:31 AM
Kaltenbach PatrickEVP & Pres Life SciencesJun 05Sale243.201,049255,11711,612Jun 05 03:07 PM
Kaltenbach PatrickEVP & Pres Life SciencesJun 02Sale244.8322254,35214,688Jun 02 02:24 PM
Fraser ClaireDirectorMay 08Sale256.56771197,80820,168May 08 02:29 PM
Khichi Samrat S.EVP and General CounselMar 16Sale224.534,349976,4815,262Mar 17 01:03 PM
Fraser ClaireDirectorFeb 11Sale258.721,500388,07420,939Feb 11 03:17 PM
Campion Simon DEVP and Segment PresidentFeb 04Option Exercise115.6813,6121,574,62115,556Feb 05 02:48 PM
Campion Simon DEVP and Segment PresidentFeb 04Sale285.098,0852,304,95310,773Feb 05 02:48 PM
Mas Ribo AlbertoEVP and Pres, Life SciencesFeb 04Sale285.001,430407,5508,381Feb 05 09:13 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Option Exercise72.1238,3622,766,667247,226Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 28Sale280.9628,5148,011,293208,864Jan 28 05:05 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Option Exercise72.1234,4062,481,361243,270Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 27Sale280.0925,5467,155,179208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Option Exercise72.129,666697,112218,530Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 24Sale280.137,1772,010,493208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Option Exercise72.128,464610,424217,328Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 23Sale280.066,2841,759,897208,864Jan 27 04:42 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Option Exercise72.1226,6651,923,080235,529Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 10Sale275.1519,6755,413,576208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Option Exercise72.1218,7831,354,630227,647Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 08Sale275.1913,8603,814,133208,864Jan 10 02:01 PM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Option Exercise72.1245,4483,277,710254,312Jan 03 09:08 AM
FORLENZA VINCENT AChairman, CEO and PresidentJan 02Sale271.2833,3659,051,257208,864Jan 03 09:08 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Option Exercise145.8013,9072,027,59027,117Dec 17 11:39 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Option Exercise134.7312,1531,637,37427,739Dec 18 09:45 AM
Mas Ribo AlbertoEVP and Pres, Life SciencesDec 16Sale269.5111,8603,196,3899,811Dec 18 09:45 AM
Polen Thomas E JrExecutive Vice PresidentDec 16Sale269.636,3861,721,85717,117Dec 17 11:39 AM
Spoerel Thomas JVP Controller & Chief Acct OffDec 13Sale267.95506135,5831,035Dec 16 09:10 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Option Exercise76.6416,3431,252,528225,393Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Option Exercise242.104,2361,025,53619,546Dec 16 09:17 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 12Sale263.2333989,23515,310Dec 16 09:17 AM
FORLENZA VINCENT AChairman, CEO and PresidentDec 12Sale265.5711,6263,087,517209,050Dec 16 09:15 AM
Kaltenbach PatrickEVP & Pres Life SciencesDec 06Sale261.5131281,59115,310Dec 06 04:11 PM
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 FINVIZ.com. All Rights Reserved.